Severe falciparum malaria with hyperparasitaemia treated with intravenous artesunate

Medical Journal of Australia

Volumn 166, Issue 8, 1997, Pages 416-418

  Davis, Timothy M E ^a,b   Breheny, Francis X ^a   Kendall, Peter A ^a   Daly, Frank ^a,b   Batty, Kevin T ^b,d   Singh, Armajit ^a,c   Llett, Kenneth F ^b,d  

^a FREMANTLE HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c Histopathology Department

^d University of Western Australia ^*

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; QUININE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FATALITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALARIA FALCIPARUM; MALE; PARASITEMIA;

EID: 0030989735     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1997.tb123192.x     Document Type: Article

References (18)

1. Warrell DA, Molyneux M, Beales P. Severe and complicated malaria. Trans R Soc Trop Med Hyg 1990; 84 (suppl 2): 1-69.
2. Hien TT, White NJ. Qinghaosu. Lancet 1993; 341: 603-608.
3. Barradell LB, Fitton A. Artesunate: a review of its pharmacology and therapeutic efficacy in the treatment of malaria. Drugs 1995; 50: 714-741.
4. Tran TH, Day NP, Nguyen HP. et al. A controlled trial of arternether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med 1996; 335: 76-83.
5. Van-Hensbroek MB, Onyiorah E, Jaffar S, et al. A trial of artemether or quinine in children with cerebral malaria. N Engl J Med 1996; 335: 69-75.
6. Ann TK, Binh TQ, Kim NV, et al. Artesunate intravenous and quinine infusive in the treatment of pernicious malaria in Viet Nam [abstract]. Proceedings of the XIVth International Congress for Tropical Medicine and Malaria; 1996 Nov; Nagasaki, Japan. Japanese Society of Parasitology, 1996.
7. World Health Organization. WHO model prescribing information: drugs used in parasitic diseases. 2nd ed. Geneva: WHO, 1995: 24-35.
8. Edwards G, Winstanley PA, Ward SA. Clinical pharmacokinetics in the treatment of tropical diseases: some applications and limitations. Clin Pharmacokinet 1994; 27: 150-165.
9. Batty KT, Davis TME, Thu LTA, et al. Selective high performance liquid Chromatographic determination of artesunate and α- and β-dihydroartemisinin in patients with falciparum malaria. J Chromatog B Biomed Appl 1996; 677: 345-350.
10. Skinner TS, Manning LS, Johnston WA, Davis TME. In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and the artemisinin drugs, int J Parasitol 1996; 26: 519-525.
11. Phillips P, Nantel S, Benny WB. Exchange transfusion as an adjunct to the treatment of severe falciparum malaria: case report and review. Rev infect Dis 1990; 12: 1100-1108.
12. Benakis A, Paris M, Plessas C, et al. Pharmacokinetics of sodium artesunate after IM and IV administration. Am J Trop Med Hyg 1993; 49 Suppl: 293.
13. Brewer TG, Peggins JO, Grate SJ, et al. Fatal neurotoxicity of arteether and artemether. Am J Trop Med Hyg 1994; 51: 215-259.
14. Alles H, Jayasunghe S, Sheriff R, Bandara S, et al. Multiple organ failure syndrome with hepatic involvement in severe and complicated malaria [abstract]. Proceedings of the XIVth International Congress for Tropical Medicine and Malaria; 1996 Nov; Nagasaki, Japan, Japanese Society of Parasitology, 1996.
15. Reynolds JEF, editor. Martindaie: the extra pharmacopoeia. 31st ed. London: The Pharmaceutical Press, 1996.
16. Prescott LF, Effects of non-narcotic analgesics on the liver. Drugs 1986; 32 Suppl 4: 129-147.
17. Chittichai P, Chierakul N, Davis TME. Peripheral gangrene in nonfatal paediatric cerebral malaria: a report of two cases. Southeast Asian J Trop Med Public Health 1991; 22: 190-194.
18. Batty KT, llett KF, Davis TME. Chemical stability of artesunate injection and proposal for its administration by intravenous infusion. J Pharm Pharmacol 1996; 48: 22-26.